Kim Nam-yong, an executive of Curiox Biosystems (CEO), reported a decrease of 570,000 shares in holdings of Curiox Biosystems stock.

Kim Nam-yong, an executive of Curiox Biosystems (CEO), filed a report on specified securities held by executives and major shareholders of Curiox Biosystems dated Oct 30, 2026. The filing states holdings of 2,240,368 shares (13.01%) after the reported change. The reported trade may have taken place before the filing date.

Written in code from the structured data of the filing. Reference information, not investment advice.

Key figures

Reporting person

Kim Nam-yong · Executive (CEO)

Registered executive

Yes

Shares held after the report

2,240,368 shares

Ownership after the report

13.01%

Change in shares

-570,000 shares

Change in ownership

-3.32 percentage points

Report date

Oct 30, 2026

Filing facts

Filing type

Insider Ownership Report

Report name

Report on Specified Securities Held by Executives and Major Shareholders

Filed

Oct 30, 2026

Receipt number

20261030000745